Loading
Latest filing published 23 Dec 2021 for Invivo Therapeutics Holdings CORP., €8.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Richard M. Toselli on record concern Invivo Therapeutics Holdings Corp. We count 16 filings; the first trade dates from 18 December 2018 and the latest from 21 December 2021.
On the open market, the record shows 1 purchase and 1 sale worth €4,507. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 14 share grants.
The newest entry dates from 23 December 2021: a share grant of €8, in Invivo Therapeutics Holdings Corp. The last purchase on record was published on 12 March 2020, which is 2,417 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations